Philips Unveils Rembra, a Scanner Capable of Imaging 270 Patients per Day
Royal Philips introduced Rembra on Thursday, a new computed tomography platform designed for high-demand and acute imaging environments. The system was publicly presented for the first time at the ECR 2026 congress in Vienna.
Rembra incorporates advanced image reconstruction technology capable of producing up to 106 images per second and supporting a high throughput of up to 270 patients per day. This architecture is aimed at accelerating diagnostics by making scanners available in near real-time. The system features the largest opening in its class with a diameter of 85 cm, accommodating patients with complex conditions and facilitating complex interventions, bariatric imaging, and trauma situations. This design aims to enhance the comfort of complex patients and potentially reduce the need for rescans.
Next-Generation Detector and AI Integration
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Rembra incorporates a next-generation NanoPanel Precise XD detector coupled with artificial intelligence, designed to deliver efficient, high-resolution dosing and imaging, supporting clear visualization and better delineation of anatomical structures. The system has received CE marking and a 510(k) application is pending.
SectorSanté · Technologie · Dispositifs médicaux›Équipements Médicaux
Context
Period
Period: 1T2026
Key reported figures
Revenue: 3.9MD€
Free cash flow: 28M€
Guidance from the release
Nous avons délivré un bon départ en 2026.
Bonne performance au T1, croissance des ventes et des marges.
Risks mentioned
Impact des tarifs et inflation des coûts sur les marges.
Environnement macroéconomique incertain impactant les performances.
Opportunities identified
Croissance des ventes comparables de 4% dans tous les segments.
Augmentation du carnet de commandes grâce à des innovations.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
